SCHEDULE 13G/A 0001660525 XXXXXXXX LIVE 1 Common shares, no par value 12/31/2025 0001997296 Medicus Pharma Ltd. 58471K202 300 Conshohocken State Road Suite 200 W. Conshohocken PA 19428 Rule 13d-1(d) Bokhari Raza X1 1218173.00 0.00 1218173.00 0.00 1218173.00 N 4.8 IN Includes: (i) 425,000 common shares underlying stock options held by Dr. Raza Bokhari that are currently exercisable or will become exercisable within 60 days of the date hereof and (ii) 793,173 common shares held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. Dr. Raza Bokhari may be deemed the beneficial owner of securities held by RBx Capital, LP. Dr. Raza Bokhari disclaims beneficial ownership of such securities except to the extent of his direct ownership. RBx Capital, LP DE 793173.00 0.00 793173.00 0.00 793173.00 N 3.2 PN Medicus Pharma Ltd. 300 Conshohocken State Road, Suite 200, W. Conshohocken, PA 19428 This statement is being filed on behalf of each of the following persons (collectively, the "Reporting Persons"): (i) Dr. Raza Bokhari; and (ii) RBx Capital, LP. The principal business address of each of the Reporting Persons is as follows: 300 Conshohocken State Rd., Suite 200 W. Conshohocken, PA 19428 See Row (4) of each Reporting Person's cover page. Y Dr. Raza Bokhari directly owns 425,000 common shares of Medicus Pharma Ltd. (the "Company") underlying stock options that are currently exercisable or will become exercisable within 60 days of the date hereof. RBx Capital, LP, an entity controlled by Dr. Raza Bokhari, directly owns 793,173 common shares. Dr. Raza Bokhari may be deemed the beneficial owner of securities held by RBx Capital, LP. Dr. Raza Bokhari disclaims beneficial ownership of such securities except to the extent of his direct ownership. See Row (11) of each Reporting Person's cover page. The percentages used herein are calculated based upon on an aggregate of 25,114,144 common shares reported by the Company to be outstanding as of December 22, 2025, as reflected in the Company's registration statement on form S-3 filed with the Commission on December 29, 2025. See Row (5) of each Reporting Person's cover page. See Row (6) of each Reporting Person's cover page. See Row (7) of each Reporting Person's cover page. See Row (8) of each Reporting Person's cover page. N Y Y Y Y Y Y Exhibit 99.1 - Joint Filing Agreement was previously filed: https://www.sec.gov/Archives/edgar/data/1660525/000095014225000305/eh250585284_ex9901.htm Bokhari Raza /s/ Raza Bokhari 01/05/2026 RBx Capital, LP /s/ Raza Bokhari 01/05/2026